产品简要
公司名称 :
赛默飞世尔
其他品牌 :
NeoMarkers, Lab Vision, Endogen, Pierce, BioSource International, Zymed Laboratories, Caltag, Molecular Probes, Research Genetics, Life Technologies, Applied Biosystems, GIBCO BRL, ABgene, Dynal, Affinity BioReagents, Nunc, Invitrogen, NatuTec, Oxoid, Richard-Allan Scientific, Arcturus, Perseptive Biosystems, Proxeon, eBioscience
产品类型 :
抗体
产品名称 :
Phospholamban Monoclonal Antibody (2D12)
目录 :
MA3-922
规格 :
100微克
价格 :
美国399.00
克隆性 :
单克隆
宿主 :
小鼠
共轭标签 :
未共轭
克隆名称 :
2D12
反应物种 :
豚鼠, 人类, 小鼠, 大鼠, 犬, 鸡, pigs , 家羊, domestic rabbit
应用 :
免疫印迹, 免疫组化, 免疫细胞化学, 免疫沉淀, 免疫组化-石蜡切片, 免疫组化-冰冻切片
更多信息或购买 :
文章摘录数: 151
出版应用/物种/样本/稀释 | 参考文献 |
---|---|
| |
| |
| |
| |
| |
| Sadredini M, Danielsen T, Aronsen J, Manotheepan R, Hougen K, Sjaastad I, et al. Beta-Adrenoceptor Stimulation Reveals Ca2+ Waves and Sarcoplasmic Reticulum Ca2+ Depletion in Left Ventricular Cardiomyocytes from Post-Infarction Rats with and without Heart Failure. PLoS ONE. 2016;11:e0153887 pubmed 出版商
|
| |
| |
| |
| |
| |
| Freire P, Alves C, Deus A, Leopoldo A, Leopoldo A, Silva D, et al. Obesity does not lead to imbalance between myocardial phospholamban phosphorylation and dephosphorylation. Arq Bras Cardiol. 2014;103:41-50 pubmed
|
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| Birkeland J, Swift F, Tovsrud N, Enger U, Lunde P, Qvigstad E, et al. Serotonin increases L-type Ca2+ current and SR Ca2+ content through 5-HT4 receptors in failing rat ventricular cardiomyocytes. Am J Physiol Heart Circ Physiol. 2007;293:H2367-76 pubmed
|
| Szczesna Cordary D, Jones M, Moore J, Watt J, Kerrick W, Xu Y, et al. Myosin regulatory light chain E22K mutation results in decreased cardiac intracellular calcium and force transients. FASEB J. 2007;21:3974-85 pubmed
|
| Pantos C, Mourouzis I, Markakis K, Dimopoulos A, Xinaris C, Kokkinos A, et al. Thyroid hormone attenuates cardiac remodeling and improves hemodynamics early after acute myocardial infarction in rats. Eur J Cardiothorac Surg. 2007;32:333-9 pubmed
|
| Stenoien D, Knyushko T, Londono M, Opresko L, Mayer M, Brady S, et al. Cellular trafficking of phospholamban and formation of functional sarcoplasmic reticulum during myocyte differentiation. Am J Physiol Cell Physiol. 2007;292:C2084-94 pubmed
|
| Armoundas A, Rose J, Aggarwal R, Stuyvers B, O ROURKE B, Kass D, et al. Cellular and molecular determinants of altered Ca2+ handling in the failing rabbit heart: primary defects in SR Ca2+ uptake and release mechanisms. Am J Physiol Heart Circ Physiol. 2007;292:H1607-18 pubmed
|
| Rodriguez P, Mitton B, Waggoner J, Kranias E. Identification of a novel phosphorylation site in protein phosphatase inhibitor-1 as a negative regulator of cardiac function. J Biol Chem. 2006;281:38599-608 pubmed
|
| Takahashi T, Tang T, Lai N, Roth D, Rebolledo B, Saito M, et al. Increased cardiac adenylyl cyclase expression is associated with increased survival after myocardial infarction. Circulation. 2006;114:388-96 pubmed
|
| Dolnikov K, Shilkrut M, Zeevi Levin N, Gerecht Nir S, Amit M, Danon A, et al. Functional properties of human embryonic stem cell-derived cardiomyocytes: intracellular Ca2+ handling and the role of sarcoplasmic reticulum in the contraction. Stem Cells. 2006;24:236-45 pubmed
|
| Yamamura K, Steenbergen C, Murphy E. Protein kinase C and preconditioning: role of the sarcoplasmic reticulum. Am J Physiol Heart Circ Physiol. 2005;289:H2484-90 pubmed
|
| Rothermel B, Berenji K, Tannous P, Kutschke W, Dey A, Nolan B, et al. Differential activation of stress-response signaling in load-induced cardiac hypertrophy and failure. Physiol Genomics. 2005;23:18-27 pubmed
|
| Tavi P, Sjogren M, Lunde P, Zhang S, Abbate F, Vennstrom B, et al. Impaired Ca2+ handling and contraction in cardiomyocytes from mice with a dominant negative thyroid hormone receptor alpha1. J Mol Cell Cardiol. 2005;38:655-63 pubmed
|
| Nakayama M, Yan X, Price R, Borg T, Ito K, Sanbe A, et al. Chronic ventricular myocyte-specific overexpression of angiotensin II type 2 receptor results in intrinsic myocyte contractile dysfunction. Am J Physiol Heart Circ Physiol. 2005;288:H317-27 pubmed
|
| Coutu P, Metzger J. Genetic manipulation of calcium-handling proteins in cardiac myocytes. I. Experimental studies. Am J Physiol Heart Circ Physiol. 2005;288:H601-12 pubmed
|
Ukropec J, Anunciado R, Ravussin Y, Hulver M, Kozak L. UCP1-independent thermogenesis in white adipose tissue of cold-acclimated Ucp1-/- mice. J Biol Chem. 2006;281:31894-908 pubmed
| |
Takaseya T, Ishimatsu M, Tayama E, Nishi A, Akasu T, Aoyagi S. Mechanical unloading improves intracellular Ca2+ regulation in rats with doxorubicin-induced cardiomyopathy. J Am Coll Cardiol. 2004;44:2239-46 pubmed
| |
van der Velden J, Merkus D, Klarenbeek B, James A, Boontje N, Dekkers D, et al. Alterations in myofilament function contribute to left ventricular dysfunction in pigs early after myocardial infarction. Circ Res. 2004;95:e85-95 pubmed
| |
Huke S, Periasamy M. Phosphorylation-status of phospholamban and calsequestrin modifies their affinity towards commonly used antibodies. J Mol Cell Cardiol. 2004;37:795-9 pubmed
| |
Liu J, Hu Q, Wang Z, Xu C, Wang X, Gong G, et al. Autologous stem cell transplantation for myocardial repair. Am J Physiol Heart Circ Physiol. 2004;287:H501-11 pubmed
| |
Suarez J, Gloss B, Belke D, Hu Y, Scott B, Dieterle T, et al. Doxycycline inducible expression of SERCA2a improves calcium handling and reverts cardiac dysfunction in pressure overload-induced cardiac hypertrophy. Am J Physiol Heart Circ Physiol. 2004;287:H2164-72 pubmed
| |
Radzyukevich T, Moseley A, Shelly D, Redden G, Behbehani M, Lingrel J, et al. The Na(+)-K(+)-ATPase alpha2-subunit isoform modulates contractility in the perinatal mouse diaphragm. Am J Physiol Cell Physiol. 2004;287:C1300-10 pubmed
| |
Gao M, Tang T, Guo T, Sun S, Feramisco J, Hammond H. Adenylyl cyclase type VI gene transfer reduces phospholamban expression in cardiac myocytes via activating transcription factor 3. J Biol Chem. 2004;279:38797-802 pubmed
| |
Remppis A, Pleger S, Most P, Lindenkamp J, Ehlermann P, Schweda C, et al. S100A1 gene transfer: a strategy to strengthen engineered cardiac grafts. J Gene Med. 2004;6:387-94 pubmed
| |
Wehrens X, Lehnart S, Reiken S, Marks A. Ca2+/calmodulin-dependent protein kinase II phosphorylation regulates the cardiac ryanodine receptor. Circ Res. 2004;94:e61-70 pubmed
| |
Yatani A, Kim S, Kudej R, Wang Q, Depre C, Irie K, et al. Insights into cardioprotection obtained from study of cellular Ca2+ handling in myocardium of true hibernating mammals. Am J Physiol Heart Circ Physiol. 2004;286:H2219-28 pubmed
| |
Waggoner J, Huffman J, Griffith B, Jones L, Mahaney J. Improved expression and characterization of Ca2+-ATPase and phospholamban in High-Five cells. Protein Expr Purif. 2004;34:56-67 pubmed
| |
Takimoto E, Soergel D, Janssen P, Stull L, Kass D, Murphy A. Frequency- and afterload-dependent cardiac modulation in vivo by troponin I with constitutively active protein kinase A phosphorylation sites. Circ Res. 2004;94:496-504 pubmed
| |
Domenech R, Sanchez G, Donoso P, Parra V, Macho P. Effect of tachycardia on myocardial sarcoplasmic reticulum and Ca2+ dynamics: a mechanism for preconditioning?. J Mol Cell Cardiol. 2003;35:1429-37 pubmed
| |
Schultz J, Glascock B, Witt S, Nieman M, Nattamai K, Liu L, et al. Accelerated onset of heart failure in mice during pressure overload with chronically decreased SERCA2 calcium pump activity. Am J Physiol Heart Circ Physiol. 2004;286:H1146-53 pubmed
| |
Kim Y, Kim S, Yatani A, Huang Y, Castelli G, Vatner D, et al. Mechanism of enhanced cardiac function in mice with hypertrophy induced by overexpressed Akt. J Biol Chem. 2003;278:47622-8 pubmed
| |
Zheng M, Dilly K, Dos Santos Cruz J, Li M, Gu Y, Ursitti J, et al. Sarcoplasmic reticulum calcium defect in Ras-induced hypertrophic cardiomyopathy heart. Am J Physiol Heart Circ Physiol. 2004;286:H424-33 pubmed
| |
Chen J, Petranka J, Yamamura K, London R, Steenbergen C, Murphy E. Gender differences in sarcoplasmic reticulum calcium loading after isoproterenol. Am J Physiol Heart Circ Physiol. 2003;285:H2657-62 pubmed
| |
Spragg D, Leclercq C, Loghmani M, Faris O, Tunin R, Disilvestre D, et al. Regional alterations in protein expression in the dyssynchronous failing heart. Circulation. 2003;108:929-32 pubmed
| |
Xu K, Kuppusamy S, Wang J, Li H, Cui H, Dawson T, et al. Nitric oxide protects cardiac sarcolemmal membrane enzyme function and ion active transport against ischemia-induced inactivation. J Biol Chem. 2003;278:41798-803 pubmed
| |
Ji Y, Li B, Reed T, Lorenz J, Kaetzel M, Dedman J. Targeted inhibition of Ca2+/calmodulin-dependent protein kinase II in cardiac longitudinal sarcoplasmic reticulum results in decreased phospholamban phosphorylation at threonine 17. J Biol Chem. 2003;278:25063-71 pubmed
| |
Jiang M, Lokuta A, Farrell E, Wolff M, Haworth R, Valdivia H. Abnormal Ca2+ release, but normal ryanodine receptors, in canine and human heart failure. Circ Res. 2002;91:1015-22 pubmed
| |
Chaudhri B, Del Monte F, Hajjar R, Harding S. Interaction between increased SERCA2a activity and beta -adrenoceptor stimulation in adult rabbit myocytes. Am J Physiol Heart Circ Physiol. 2002;283:H2450-7 pubmed
| |
Choi K, Zhong Y, Hoit B, Grupp I, Hahn H, Dilly K, et al. Defective intracellular Ca(2+) signaling contributes to cardiomyopathy in Type 1 diabetic rats. Am J Physiol Heart Circ Physiol. 2002;283:H1398-408 pubmed
| |
Huke S, Prasad V, Nieman M, Nattamai K, Grupp I, Lorenz J, et al. Altered dose response to beta-agonists in SERCA1a-expressing hearts ex vivo and in vivo. Am J Physiol Heart Circ Physiol. 2002;283:H958-65 pubmed
| |
Hong C, Cho M, Kwak Y, Song C, Lee Y, Lim J, et al. Cardiac remodeling and atrial fibrillation in transgenic mice overexpressing junctin. FASEB J. 2002;16:1310-2 pubmed
| |
Liu W, Yasui K, Opthof T, Ishiki R, Lee J, Kamiya K, et al. Developmental changes of Ca(2+) handling in mouse ventricular cells from early embryo to adulthood. Life Sci. 2002;71:1279-92 pubmed
| |
Carr A, Schmidt A, Suzuki Y, Del Monte F, Sato Y, Lanner C, et al. Type 1 phosphatase, a negative regulator of cardiac function. Mol Cell Biol. 2002;22:4124-35 pubmed
| |
Trost S, Belke D, Bluhm W, Meyer M, Swanson E, Dillmann W. Overexpression of the sarcoplasmic reticulum Ca(2+)-ATPase improves myocardial contractility in diabetic cardiomyopathy. Diabetes. 2002;51:1166-71 pubmed
| |
Del Monte F, Harding S, Dec G, Gwathmey J, Hajjar R. Targeting phospholamban by gene transfer in human heart failure. Circulation. 2002;105:904-7 pubmed
| |
Song L, Guia A, Muth J, Rubio M, Wang S, Xiao R, et al. Ca(2+) signaling in cardiac myocytes overexpressing the alpha(1) subunit of L-type Ca(2+) channel. Circ Res. 2002;90:174-81 pubmed
| |
Toma C, Pittenger M, Cahill K, Byrne B, Kessler P. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation. 2002;105:93-8 pubmed
| |
Most P, Bernotat J, Ehlermann P, Pleger S, Reppel M, Borries M, et al. S100A1: a regulator of myocardial contractility. Proc Natl Acad Sci U S A. 2001;98:13889-94 pubmed
| |
Kapiloff M, Jackson N, Airhart N. mAKAP and the ryanodine receptor are part of a multi-component signaling complex on the cardiomyocyte nuclear envelope. J Cell Sci. 2001;114:3167-76 pubmed
| |
Zhong Y, Ahmed S, Grupp I, Matlib M. Altered SR protein expression associated with contractile dysfunction in diabetic rat hearts. Am J Physiol Heart Circ Physiol. 2001;281:H1137-47 pubmed
| |
Meyer M, Trost S, Bluhm W, Knot H, Swanson E, Dillmann W. Impaired sarcoplasmic reticulum function leads to contractile dysfunction and cardiac hypertrophy. Am J Physiol Heart Circ Physiol. 2001;280:H2046-52 pubmed
| |
Dash R, Kadambi V, Schmidt A, Tepe N, Biniakiewicz D, Gerst M, et al. Interactions between phospholamban and beta-adrenergic drive may lead to cardiomyopathy and early mortality. Circulation. 2001;103:889-96 pubmed
| |
Cavagna M, O Donnell J, Sumbilla C, Inesi G, Klein M. Exogenous Ca2+-ATPase isoform effects on Ca2+ transients of embryonic chicken and neonatal rat cardiac myocytes. J Physiol. 2000;528 Pt 1:53-63 pubmed
| |
Zhang L, Zhang X, Ng Y, Rothblum L, Musch T, Moore R, et al. Sprint training normalizes Ca(2+) transients and SR function in postinfarction rat myocytes. J Appl Physiol (1985). 2000;89:38-46 pubmed
| |
Froemming G, Murray B, Harmon S, Pette D, Ohlendieck K. Comparative analysis of the isoform expression pattern of Ca(2+)-regulatory membrane proteins in fast-twitch, slow-twitch, cardiac, neonatal and chronic low-frequency stimulated muscle fibers. Biochim Biophys Acta. 2000;1466:151-68 pubmed
| |
Zhai J, Schmidt A, Hoit B, Kimura Y, MacLennan D, Kranias E. Cardiac-specific overexpression of a superinhibitory pentameric phospholamban mutant enhances inhibition of cardiac function in vivo. J Biol Chem. 2000;275:10538-44 pubmed
| |
O ROURKE B, Kass D, Tomaselli G, Kaab S, Tunin R, Marban E. Mechanisms of altered excitation-contraction coupling in canine tachycardia-induced heart failure, I: experimental studies. Circ Res. 1999;84:562-70 pubmed
| |
Xu K, Huso D, Dawson T, Bredt D, Becker L. Nitric oxide synthase in cardiac sarcoplasmic reticulum. Proc Natl Acad Sci U S A. 1999;96:657-62 pubmed
| |
Takeishi Y, Chu G, Kirkpatrick D, Li Z, Wakasaki H, Kranias E, et al. In vivo phosphorylation of cardiac troponin I by protein kinase Cbeta2 decreases cardiomyocyte calcium responsiveness and contractility in transgenic mouse hearts. J Clin Invest. 1998;102:72-8 pubmed
| |
Reddy L, Jones L, Pace R, Stokes D. Purified, reconstituted cardiac Ca2+-ATPase is regulated by phospholamban but not by direct phosphorylation with Ca2+/calmodulin-dependent protein kinase. J Biol Chem. 1996;271:14964-70 pubmed
| |
Jones L, Field L. Residues 2-25 of phospholamban are insufficient to inhibit Ca2+ transport ATPase of cardiac sarcoplasmic reticulum. J Biol Chem. 1993;268:11486-8 pubmed
| |
Jorgensen A, Shen A, Arnold W, McPherson P, Campbell K. The Ca2+-release channel/ryanodine receptor is localized in junctional and corbular sarcoplasmic reticulum in cardiac muscle. J Cell Biol. 1993;120:969-80 pubmed
| |
Cantilina T, Sagara Y, Inesi G, Jones L. Comparative studies of cardiac and skeletal sarcoplasmic reticulum ATPases. Effect of a phospholamban antibody on enzyme activation by Ca2+. J Biol Chem. 1993;268:17018-25 pubmed
| |
Movsesian M, Karimi M, Green K, Jones L. Ca(2+)-transporting ATPase, phospholamban, and calsequestrin levels in nonfailing and failing human myocardium. Circulation. 1994;90:653-7 pubmed
| |
Hu P, Yin C, Zhang K, Wright L, Nixon T, Wechsler A, et al. Transcriptional regulation of phospholamban gene and translational regulation of SERCA2 gene produces coordinate expression of these two sarcoplasmic reticulum proteins during skeletal muscle phenotype switching. J Biol Chem. 1995;270:11619-22 pubmed
| |
Sham J, Jones L, Morad M. Phospholamban mediates the beta-adrenergic-enhanced Ca2+ uptake in mammalian ventricular myocytes. Am J Physiol. 1991;261:H1344-9 pubmed
| |
Briggs F, Lee K, Wechsler A, Jones L. Phospholamban expressed in slow-twitch and chronically stimulated fast-twitch muscles minimally affects calcium affinity of sarcoplasmic reticulum Ca(2+)-ATPase. J Biol Chem. 1992;267:26056-61 pubmed
|
产品信息
产品类型 :
抗体
产品名称 :
Phospholamban Monoclonal Antibody (2D12)
目录# :
MA3-922
规格 :
100微克
价格 :
美国399.00
克隆性 :
单克隆
纯度 :
蛋白质A
宿主 :
小鼠
反应物种 :
Canine, Chicken, Guinea Pig, Human, Mouse, Ovine, Porcine, Rabbit, Rat
应用 :
Immunocytochemistry: 1:10-1:100, Immunohistochemistry (Paraffin): 1:200, Immunoprecipitation: Assay-dependent, Western Blot: 1:500-1:5,000
物种 :
Canine, Chicken, Guinea Pig, Human, Mouse, Ovine, Porcine, Rabbit, Rat
克隆 :
2D12
抗体亚型 :
IgG2a
储存 :
-20° C, 避免反复冷冻/解冻
描述 :
Phospholamban (PLB) is a 52 amino acid phosphoprotein which regulates the calcium pump of cardiac sarcoplasmic reticulum (SR). PLB is an oligomer of five identical subunits each having a cytoplasmic and transmembrane domain. The cytoplasmic domain (residues 1 to 25) contains the phosphorylation sites and is highly basic and readily cleaved by proteases whereas the transmembrane domain (residues 25 to 52) is mostly hydrophobic, protease resistant and stabilizes the pentamer.
免疫原 :
Synthetic peptide corresponding to residues D(2) K V Q Y L T R S A I R R A S T I E M P Q Q A R(25) of canine Phospholamban.
格式 :
液体
应用w/稀释 :
Immunocytochemistry: 1:10-1:100, Immunohistochemistry (Paraffin): 1:200, Immunoprecipitation: Assay-dependent, Western Blot: 1:500-1:5,000
别名 :
cardiac CMH18; Cardiac phospholamban; CMD1P; CMH18; phospholamban; Plb; Plm; PLN; unnamed protein product
更多信息或购买 :
公司信息
赛默飞世尔